News

LoneStar Heart Inc.Algisyl-LVR Hydrogel Implant Heart Failure Treatment CE Mark

LoneStar Heart Inc. announced that it received the CE mark (Conformite Europeene) for its Algisyl-LVR hydrogel implant, the company's lead product for the treatment of advanced heart failure (HF...

Preventice Three-in-one Switchability BodyGuardian Remote Monitoring System

Preventice Inc. announced improvements to its BodyGuardian Remote Monitoring System that have the potential to simplify the remote monitoring experience for patients and contribute to a more...

This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and operator.

CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV ECLS) kit was utilized Sept. 24, at Memorial Hermann Hospital in Houston.

Stanford Children’s Health Lighthaus Inc. Pediatric Heart Procedures 3-D graphic

Stanford Children’s Health is using cutting-edge videogame technology to get parents the information they need about the complex medical procedures their children might face. 

October 8, 2014 — At the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting, representatives from Cardinal Health and physicians from leading healthcare institutions led discussions to...

October 8, 2014 — New updates to the Society for Cardiovascular Angiography and Interventions (SCAI) appropriate use criteria (AUC) calculator tool will help healthcare providers in making...

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is more cost effective and offers a...

Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total patient population. Recover Right was an FDA-approved, prospective, multicenter, single arm study...

Twelve-month Data St. Jude Medical EnligHTN Renal Denervation System

St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III study, which demonstrated a continuation of safe, rapid and effective treatment with the next-generation EnligHTN Renal...

More than 40 percent of Americans aged 40 and older have experienced one or more of the most common symptoms[1] of peripheral arterial disease (PAD).

October 8, 2014 — Miracor Medical Systems announced that results from the prospective multicenter safety and feasibility study, ‘Prepare RAMSES,’ were presented at the annual Transcatheter...

Claret Medical announced the first patient has been successfully treated in its SENTINEL trial, a multicenter pivotal trial of the Sentinel cerebral protection system (CPS). The landmark trial is...

Amaranth Medical announced patient enrollment in multiple centers in Colombia, South America in MEND-II, a clinical trial to assess safety and feasibility of the company's Fortitude...

Medtronic SEEQ Wearable Cardiac Monitoring System United States Launch

Medtronic Inc. announced the U.S. launch of the SEEQ Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor that can be worn for up to 30 days to help detect and...

Occlutech CE mark Dedicated Paravalvular Leak Closure Device

Occlutech  announced that it has obtained a European CE mark approval for its dedicated Paravalvular Leak Closure Device (PLD).

ASEF Grant Echo Can Dt Coronary Lesions Chest Pain Patients

The ASE Education and Research Foundation hosted a one-day event, Value-Based Healthcare: Summit 2014, Sept. 12 in Washington, D.C., which gathered thought leaders from across the healthcare...

St. Vincent Implant Thoratec Corp. HeartMate III VAD

St. Vincent Heart Center officials announced that the faith-based hospital is the second in the nation to implant the new investigational “heart pump.”

Ekos for PE

Acute intermediate-risk pulmonary emboli (PE) in normotensive patients with right ventricle dysfunction present the clinician with a quandary. With a 3 percent mortality rate[1] — just shy of the...

October 3, 2014 — Esaote North America announced that its new MyLab Gamma ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for...